Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia.

Authors : Peinert, Stefan^1,2,3 (AUTHOR); Tam, Constantine S.⁴ (AUTHOR); Prince, H. Miles^1,2,5 (AUTHOR)

Source: Leukemia & Lymphoma. Dec2010, Vol. 51 Issue 12, p2188-2197. 10p. 4 Charts, 2 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Treatment of patients with fludarabine-refractory chronic lymphocytic leukemia: need for new treatment options.

Authors : Tsimberidou, Apostolia-Maria¹ (AUTHOR) ; Keating, Michael J.¹ (AUTHOR)

Source: Leukemia & Lymphoma. Jul2010, Vol. 51 Issue 7, p1188-1199. 12p. 4 Charts.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies.

Authors : Holtan, S. G.¹; Hogan, W. J.¹; Elliott, M. A.¹

Source: Bone Marrow Transplantation. Dec2010, Vol. 45 Issue 12, p1699-1703. 5p. 2 Charts, 1 Graph.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Combination of Fludarabine and Imatinib Induces Apoptosis Synergistically Through Loss of Mitochondrial Membrane Potential and Increases in Caspase-3 Enzyme Activity in Human K562 Chronic Myleloid Leukemia Cells.

Authors : Baran, Yusuf¹ (AUTHOR); Oztekin, Coskun² (AUTHOR); Bassoy, Esen Yonca¹ (AUTHOR)

Source: Cancer Investigation. Jul2010, Vol. 28 Issue 6, p623-628. 6p. 6 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT.

Authors : Cable, C.¹; Buzzeo, M. P.²; Schold, J. D.³

Source: Bone Marrow Transplantation. Jan2010, Vol. 45 Issue 1, p31-37. 7p. 1 Diagram, 2 Charts, 2 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.

Authors : O'Donnell, Peter H.^1,2 (AUTHOR); Artz, Andrew S.¹ (AUTHOR); Undevia, Samir D.¹ (AUTHOR)

Source: Leukemia & Lymphoma. Dec2010, Vol. 51 Issue 12, p2240-2249. 10p. 1 Diagram, 3 Charts, 1 Graph.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders.

Authors : Cassano, Carlos¹; Mactier, Swetlana¹ ; Mulligan, Stephen P.^1,2

Source: International Journal of Proteomics. 2010, p1-9. 9p. 1 Black and White Photograph, 1 Chart, 2 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.

Authors : Carney, D. A.^1,2 ; Westerman, D. A.^1,2; Tam, C. S.³

Source: Leukemia (08876924). Dec2010, Vol. 24 Issue 12, p2056-2062. 7p. 2 Charts, 1 Graph.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants.

Authors : George, B.¹; Kerridge, I.¹; Gilroy, N.²

Source: Bone Marrow Transplantation. May2010, Vol. 45 Issue 5, p849-855. 7p. 5 Charts, 2 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Stem Cell Transplantation Using Non-myeloablative Conditioning Regimen with Fludarabine for Hematological Malignancies.

Authors : Tajika, Kenji¹ ; Yamaguchi, Hiroki¹; Mizuki, Taro¹

Source: Journal of Nippon Medical School. 2010, Vol. 77 Issue 5, p254-259. 6p. 1 Chart, 2 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia.

Treatment of patients with fludarabine-refractory chronic lymphocytic leukemia: need for new treatment options.

CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies.

Combination of Fludarabine and Imatinib Induces Apoptosis Synergistically Through Loss of Mitochondrial Membrane Potential and Increases in Caspase-3 Enzyme Activity in Human K562 Chronic Myleloid Leukemia Cells.

Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT.

Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.

Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders.

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.

Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants.

Stem Cell Transplantation Using Non-myeloablative Conditioning Regimen with Fludarabine for Hematological Malignancies.

اتصل بنا

اتبع